Related Experiment Video

Updated: Jul 19, 2026

Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay
06:08

Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay

Published on: September 22, 2023

Pathogenesis of chronic rhinosinusitis

Paul Van Cauwenberge1, Helen Van Hoecke, Claus Bachert

  • 1Department of Otorhinolaryngology, Ghent University, De Pintelaan 185, 9000 Ghent, Belgium. paul.vancauwenberge@ugent.be

Current Allergy and Asthma Reports
|October 20, 2006
PubMed

Insights

Chronic rhinosinusitis (CRS) is complex, with potential factors including infections and genetics. Nasal polyposis (NP) shows distinct eosinophilic inflammation, suggesting it

Area of Science:

  • Otolaryngology and immunology
  • Inflammatory diseases research

Background:

  • Chronic rhinosinusitis (CRS) is a prevalent, heterogeneous disorder with incompletely understood etiology.
  • Despite advances, the exact causes and persistence mechanisms of CRS remain elusive.
  • Potential contributing factors include impaired mucociliary clearance, infections, allergies, and genetic predispositions.

Purpose of the Study:

  • To differentiate the distinct pathologies of chronic rhinosinusitis (CRS) and nasal polyposis (NP).
  • To investigate the inflammatory patterns and molecular profiles in CRS and NP.

Main Methods:

  • Histopathological analysis of sinonasal tissues.
  • Assessment of inflammatory patterns and cytokine profiles.
  • Evaluation of immunoglobulin E (IgE) production and response to Staphylococcus-derived superantigens.

Main Results:

  • Nasal polyposis (NP) exhibits abundant eosinophilic inflammation and local IgE production, unlike CRS without NP.
  • Staphylococcus-derived superantigens may influence disease severity and expression in NP.
  • Distinct inflammatory profiles and remodeling processes characterize CRS and NP.

Conclusions:

  • Findings challenge the classification of NP as a subgroup of CRS.
  • CRS and NP should be considered separate disease entities based on differing pathomechanisms.
  • Further research into distinct inflammatory pathways is warranted for targeted therapies.

More Related Videos

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions09:02

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions

Published on: September 22, 2023

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites09:52

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

Published on: August 8, 2014

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...